Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

FcgammaR and multiple sclerosis: an overview.

O Torkildsen1, C A Vedeler, H I Nyland

  • 1The Multiple Sclerosis National Competence Centre, Department of Neurology, Haukeland University Hospital and Department of Clinical Medicine, Section for Neurology, University of Bergen, Bergen, Norway. oivind.torkildsen@gmail.com

Acta Neurologica Scandinavica. Supplementum
|April 28, 2006
PubMed
Summary

Fc receptors (FcgammaR) are crucial immune system components. Their role in multiple sclerosis (MS) is understudied but may impact disease progression and treatment response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis.

Multiple sclerosis and related disorders·2024
Same author

Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study.

Journal of neurology·2023
Same author

Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation.

Case reports in immunology·2022
Same author

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial.

Multiple sclerosis journal - experimental, translational and clinical·2019
Same author

Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients'.

European journal of neurology·2018
Same author

The economic impact of multiple sclerosis to the patients and their families in Norway.

The European journal of health economics : HEPAC : health economics in prevention and care·2018

Area of Science:

  • Immunology
  • Neuroimmunology
  • Multiple Sclerosis Research

Background:

  • Fc receptors for the IgG Fc domain (FcgammaR) are critical mediators linking cellular and humoral immunity.
  • While CNS-specific antibodies in multiple sclerosis (MS) are well-documented, the function of FcgammaR in MS pathogenesis is largely unknown.

Purpose of the Study:

  • To explore the potential role of FcgammaR in multiple sclerosis.
  • To investigate how FcgammaR may influence disease progression and therapeutic outcomes in MS.

Main Methods:

  • Review of existing literature on FcgammaR, IgG antibodies, and MS.
  • Analysis of studies investigating FcgammaR gene polymorphisms.
  • Examination of research on FcgammaR-modulating therapies in autoimmune diseases.

Related Experiment Videos

Main Results:

  • FcgammaR are integral to immune responses, bridging innate and adaptive immunity.
  • Evidence suggests FcgammaR gene polymorphisms may affect MS susceptibility or severity.
  • Therapies targeting FcgammaR expression on immune cells could impact MS disease course.

Conclusions:

  • FcgammaR represent a significant, yet underappreciated, factor in multiple sclerosis.
  • Further research into FcgammaR function and therapeutic targeting is warranted for MS management.
  • Understanding FcgammaR's role could lead to novel strategies for MS treatment and prevention.